References

Cancer treatment-induced bone loss: pathophysiology and clinical perspectives

10.1634/theoncologist.2007-0152 · 2008 · External reference

Bone health in cancer patients: ESMO Clinical Practice Guidelines

10.1093/annonc/mdu103 · 2014 · External reference

Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer

10.1007/s00198-016-3899-6 · 2017 · External reference

Bone loss and fracture risk associated with cancer therapy

10.1634/theoncologist.11-10-1121 · 2006 · External reference

Update on imaging-based measurement of bone mineral density and quality

10.1007/s11926-020-00892-w · 2020 · External reference

Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice

10.1016/j.bone.2015.05.016 · 2015 · External reference

Application and prospect of trabecular bone score in differentiated thyroid cancer patients receiving thyrotropin suppression therapy

10.3389/fendo.2022.1004962 · 2022 · External reference

Insulin resistance, bone health, and fracture risk

10.1007/s00198-024-07227-w · 2024 · External reference

Insulin resistance and bone mineral density: A comprehensive examination using UK biobank data

10.3390/healthcare12242502 · 2024 · External reference

A systematic review of the association between insulin resistance surrogate indices and bone mineral density

10.3389/fendo.2024.1499479 · 2024 · External reference

Relationship between insulin resistance (HOMA-IR), trabecular bone score (TBS), and three-dimensional dual-energy X-ray absorptiometry (3D-DXA) in non-diabetic postmenopausal women

10.3390/jcm9061732 · 2020 · External reference

METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes

10.1530/eje-17-0883 · 2018 · External reference

Predictive values of metabolic score for insulin resistance on risk of major adverse cardiovascular events and comparison with other insulin resistance indices among Chinese with and without diabetes mellitus: Results from the 4C cohort study

10.1111/jdi.14024 · 2023 · External reference

A simulation study of the number of events per variable in logistic regression analysis

10.1016/s0895-4356(96)00236-3 · 1996 · External reference

Bone mineral densitometry reporting: pearls and pitfalls

10.1177/0846537120919627 · 2021 · External reference

Bone metastases and health in prostate cancer: from pathophysiology to clinical implications

10.3390/cancers15051518 · 2023 · External reference

Assessment of bone turnover markers and DXA parameters to predict bone metastasis progression during zoledronate treatment: a single-center experience

10.1007/s10238-023-01280-1 · 2024 · External reference

Trabecular bone score in adults with type 1 diabetes: a meta-analysis

10.1007/s00198-023-06935-z · 2024 · External reference

Trabecular bone score (TBS) in individuals with type 2 diabetes mellitus: an updated review

10.3390/jcm12237399 · 2023 · External reference

AGEs (Advanced Glycation End-products) in bone come of age

10.1016/j.bone.2024.117301 · 2025 · External reference

Advanced glycation and glycoxidation end products in bone

10.1016/j.bone.2023.116880 · 2023 · External reference

Adipokines: masterminds of metabolic inflammation

10.1038/s41577-024-01103-8 · 2025 · External reference

Adipokines, hepatokines and myokines: focus on their role and molecular mechanisms in adipose tissue inflammation

10.3389/fendo.2022.873699 · 2022 · External reference

Reappraisal of adipose tissue inflammation in obesity

10.1007/978-3-031-63657-8_10 · 2024 · External reference

Age- and sex-related changes in bone microarchitecture and estimated strength: A three-year prospective study using HRpQCT

10.1002/jbmr.2817 · 2016 · External reference